Next Article in Journal
A Novel Effective and Safe Vaccine for Prevention of Marek’s Disease Caused by Infection with a Very Virulent Plus (vv+) Marek’s Disease Virus
Next Article in Special Issue
Development of Pandemic Vaccines: ERVEBO Case Study
Previous Article in Journal
Vaccine Development for Herpes Simplex Viruses: A Commentary of Special Issue Editors
Previous Article in Special Issue
Construction and Immunogenicity Comparison of Three Virus-Like Particles Carrying Different Combinations of Structural Proteins of Avian Coronavirus Infectious Bronchitis Virus
 
 
Article

Article Versions Notes

Vaccines 2021, 9(2), 157; https://doi.org/10.3390/vaccines9020157
Action Date Notes Link
article xml file uploaded 16 February 2021 13:32 CET Original file -
article xml uploaded. 16 February 2021 13:32 CET Update https://www.mdpi.com/2076-393X/9/2/157/xml
article pdf uploaded. 16 February 2021 13:32 CET Version of Record https://www.mdpi.com/2076-393X/9/2/157/pdf
article html file updated 16 February 2021 13:34 CET Original file -
article html file updated 25 July 2022 03:44 CEST Update https://www.mdpi.com/2076-393X/9/2/157/html
Back to TopTop